Ignite Creation Date:
2024-05-05 @ 5:09 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00392665
Status:
TERMINATED
Last Update Posted:
2017-04-13
First Post:
2006-10-24
Brief Title:
BevacizumabTarceva and TarcevaSulindac in Squamous Cell Carcinoma of the Head and Neck
Sponsor:
Organization:
Massachusetts General Hospital